MW |
glomerular filtration rate |
right nephrectomy (for 112 days) then angiotensin II receptor antagonist (80 mg/l) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
glomerular filtration trait |
male |
0 days
| 5 |
0.42 |
ml/min |
0.06 |
0.13 |
inulin analysis by liquid phase colorimetry |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100889 |
2523 |
MW |
glomerular filtration rate |
control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
glomerular filtration trait |
male |
0 days
| 18 |
0.99 |
ml/min |
0.08 |
0.34 |
inulin analysis by liquid phase colorimetry |
0.0 |
control |
29 |
days |
101208 |
2581 |
MW |
glomerular filtration rate |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
glomerular filtration trait |
male |
0 days
| 8 |
0.61 |
ml/min |
0.08 |
0.23 |
inulin analysis by liquid phase colorimetry |
0.0 |
5/6 nephrectomy |
28 |
days |
100994 |
2561 |
MW |
glomerular filtration rate |
unilateral nephrectomy (for 70 days) and captopril (500 mg/l) (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
glomerular filtration trait |
male |
0 days
| 5 |
0.94 |
ml/min |
0.11 |
0.25 |
inulin analysis by liquid phase colorimetry |
0.0 |
unx |
70 |
days |
101206 |
2581 |
MW |
glomerular filtration rate |
right nephrectomy (for 112 days) then captopril (30 mg/kg/d) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
glomerular filtration trait |
male |
0 days
| 10 |
0.67 |
ml/min |
0.1 |
0.32 |
inulin analysis by liquid phase colorimetry |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100885 |
2523 |
MW |
glomerular filtration rate |
nephrectomy (for 28 days) then enalapril (50 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
glomerular filtration trait |
male |
0 days
| 8 |
0.54 |
ml/min |
0.05 |
0.14 |
inulin analysis by liquid phase colorimetry |
0.0 |
5/6 nephrectomy |
28 |
days |
100993 |
2561 |
MW |
glomerular filtration rate |
right nephrectomy (for 112 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
glomerular filtration trait |
male |
0 days
| 6 |
0.05 |
ml/min |
0.01 |
0.02 |
inulin analysis by liquid phase colorimetry |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100883 |
2523 |
MW |
glomerular filtration rate |
right nephrectomy (for 112 days) then enalapril (20 mg/kg/d) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
glomerular filtration trait |
male |
0 days
| 9 |
0.38 |
ml/min |
0.1 |
0.3 |
inulin analysis by liquid phase colorimetry |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100886 |
2523 |
MW |
glomerular filtration rate |
right nephrectomy (for 112 days) then angiotensin II receptor antagonist (20 mg/l) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
glomerular filtration trait |
male |
0 days
| 7 |
0.36 |
ml/min |
0.06 |
0.16 |
inulin analysis by liquid phase colorimetry |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100888 |
2523 |
MW |
glomerular filtration rate |
unilateral nephrectomy (for 70 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
glomerular filtration trait |
male |
0 days
| 7 |
1.46 |
ml/min |
0.08 |
0.21 |
inulin analysis by liquid phase colorimetry |
0.0 |
unx |
70 |
days |
101205 |
2581 |
MW |
glomerular filtration rate |
doxorubicin (2 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
glomerular filtration trait |
male |
0 days
| 7 |
0.41 |
ml/min |
0.1 |
0.26 |
inulin analysis by liquid phase colorimetry |
0.0 |
doxorubicin |
29 |
days |
101207 |
2581 |
MW |
glomerular filtration rate |
right nephrectomy (for 112 days) then lisinopril (10 mg/kg/d) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
glomerular filtration trait |
male |
0 days
| 10 |
0.36 |
ml/min |
0.05 |
0.16 |
inulin analysis by liquid phase colorimetry |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100887 |
2523 |
MW |
glomerular filtration rate |
right nephrectomy (for 112 days) then reserpine (5 mg/l) (for 56 days) and hydralazine (80 mg/l) (for 56 days) and controlled hydralazine content drinking water (25 mg/l) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
glomerular filtration trait |
male |
0 days
| 10 |
0.32 |
ml/min |
0.01 |
0.03 |
inulin analysis by liquid phase colorimetry |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100884 |
2523 |
MW |
glomerular filtration rate |
unilateral nephrectomy (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
glomerular filtration trait |
male |
0 days
| 6 |
0.57 |
ml/min |
0.07 |
0.17 |
inulin analysis by liquid phase colorimetry |
0.0 |
unx |
70 |
days |
101204 |
2581 |
MW |
glomerular filtration rate |
nephrectomy (for 28 days) then control condition |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
glomerular filtration trait |
male |
0 days
| 8 |
0.6 |
ml/min |
0.07 |
0.2 |
inulin analysis by liquid phase colorimetry |
0.0 |
5/6 nephrectomy |
28 |
days |
100992 |
2561 |